Vaginitis Therapeutics Market (By Product: Anti-fungal, Anti-bacterial, Hormone; By Type: Over-The-Counter (OTC), Prescription (Rx)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global vaginitis therapeutics market size is anticipated to around USD 4.5 billion by 2026, this market is anticipated to grow with 9.0% CAGR during the forecast time period.

Market Dynamics

Expanding mindfulness about ladies' wellbeing, introduction of new medications by key organizations, and rising need for improved healthcare infrastructure are a portion of the main considerations driving the market.

As per the Centers for Disease Control and Prevention (CDC), in 2015, more than 13 of each 100 ladies were cigarette smokers. The National Institute of Allergy and Infectious Diseases (NIAID) supported researchers to build up the test for yeast contamination in order to give suitable enemy of parasitic treatment. Likewise, NICHD specialists inside the Division of Intramural Population Health inquire about (DIPHR) are utilizing past and recently gathered information to investigate different parts of relationship between bacterial vaginosis and pregnancy result.

Market Insights

Based on type, market is segmented into Over-The-Counter (OTC) and prescription (Rx). Among these, prescribed type represents the larger market share of the overall industry owing to higher effectiveness and safety for severe and recurring vaginitis. OTC is relied upon to extend at a CAGR of 8.7% during the coming years because of the nearness of wide scope of OTC medications, for example, vaginal creams, gels, and others. Besides, for non-prescribed drugs, FDA has affirmed treatment alternatives for gentle vaginitis for outside use. These incorporate tioconazole miconazole, clotrimazole, and butoconazole as cream, tablets, and suppositories.

Based on product, vaginitis therapeutics market is bifurcated into anti-fungal, anti-bacterial, and hormone. Anti-bacterial segment capture the largest market share due to increasing cases of bacterial vaginosis. This segment was valued at USD 990 million in 2018, in terms of revenue. It was reported that about 21 million women were suffering from this disease. Drugs used for the treatment of clindamycin, bacterial vaginosis metronidazole, and tinidazole.

Market Segmentation

Market By Product

  • Anti-fungal
  • Anti-bacterial
  • Hormone

Market By Type

  • Over-The-Counter (OTC)
  • Prescription (Rx)

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America drove the worldwide market in 2017 and was esteemed at USD 861.2 million. Set up healthcare infrastructure in this region alongside occurrence of key producers is a main parameters responsible for its largest share. Different components, for example, good government activities and developing target populace are likewise pushing the market development.

Asia Pacific is evaluated to observe the quickest development with CAGR of around 9.6% during the coming years. This is credited to high neglected clinical necessities, rising disposable income and expanded mindfulness about early conclusion, and accessibility of powerful medications in rising nations, for example, India and China.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with thevaginitis therapeutics areMission Pharmacal Company, Pfizer, Inc., Symbiomix Therapeutics, Inc., Novartis AG, Merck & Co., Lupin Pharmaceuticals, Inc., and Bayer AG.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary